About Diabetes
Complications
Warning Signs
Screening Test
Donate Now
E-Lerts™
Index
Latest News
Diabetes Terms
Health & Fitness
Online Press Center
Did You Know?
posted 03/30/2006
There are currently more than 194 million people with diabetes worldwide. If nothing is done to slow the epidemic, the number will exceed 333 million by 2025.
According to the
IDF Diabetes Atlas 2nd edition, in 2003
the five countries with the largest numbers of persons with diabetes were India
(35.5 million), China (23.8 million), the United States (16 million), Russia
(9.7 million) and Japan (6.7 million).
In 2003, the five countries with the highest diabetes prevalence in the adult
population were Nauru (30.2 %), The United Arab Emirates (20.1 %), Qatar (16%),
Bahrain(14.9%), and Kuwait (12.8%).
At least 50% of all people with diabetes are unaware of their condition. In some countries this figure may rise to 80%.
Diabetes is the fourth main cause of death in most developed countries.
Diabetes is the leading cause of blindness and visual impairment in adults in developed countries.
Diabetes is the most common cause of
amputation which is not the result of an accident.
People with diabetes are 15 to 40 times more likely to require a lower-limb
amputation compared to the general population.
Cardiovascular disease is the number one cause of death in industrialized countries. It is also set to overtake infectious diseases as the most common cause of death in many parts of the less developed world.
People with diabetes are two to four times more likely to develop cardiovascular disease than people without diabetes.
People with type 2 diabetes have the same risk of heart attack as people without diabetes who have already had a heart attack.
People with diabetes can have a heart attack without even realising it.
Strokes occur twice as often in people with diabetes and high blood presure as in those with high blood pressure alone.
For each risk factor present, the risk of cardiovascular death is about three times greater in people with diabetes as compared to people without the condition.
While cardiovascular disease mortality and in particular coronary heart disease related deaths have declined in those without diabetes in developed countries, in men with diabetes the decrease has been a modest 13% while in women with diabetes the rates have actually increased by 23%.
By 2025, the number of people with diabetes is expected to more than double in Africa, the Eastern Mediterranean and Middle East, and South-East Asia, and rise by 20% in Europe, 50% in North America, 85% in South and Central America and 75% in the Western Pacific.
For developing countries, there will be a projected increase of a 170% of cases; for developed countries, there will be a projected rise of 42%.
The populations of most countries are ageing. Diabetes is particularly common in ageing populations and is increasing in proportion to the number of people living longer.
The devastating complications of diabetes, such as blindness, kidney failure and heart disease, are imposing a huge burden on healthcare services. It is estimated that diabetes accounts for between 5% and 10% of a nation's health budget.
The human and economic costs of diabetes could be significantly reduced by investing in prevention, particularly early detection, in order to avoid the onset of diabetic complications.
There is conclusive evidence that good control of blood glucose levels can substantially reduce the risk of developing complications and slow their progression in all types of diabetes. The management of high blood pressure and raised blood lipids (fats) is equally important. In all societies, better control of these parameters would contribute to a substantial improvement of quality of life.
An estimated 25% of the world's nations have not made any specific provision for diabetes care in national health plans.
Diabetes increased by one-third during the 1990s, due to the prevalence of obesity and an aging population.
In 2002, the IDF Task Force on
Insulin, Test Strips and Other Diabetes Supplies conducted its second survey
on the access to and availability of insulin in IDF member countries. Of the 74
countries that participated, 30 admitted that they could not ensure a continuous
supply of insulin to people with type 1 diabetes. The situation is especially
severe in sub-Saharan Africa where no country can ensure 100% access to
insulin. A similar survey in 1997 showed that continual access to insulin,
syringes and needles was greater in urban than in rural areas (48 countries vs
32 for insulin; 41 vs 29 for syringes and needles).
Sources:
Diabetes Atlas, second edition, International Diabetes Federation, 2003.
Diabetes and Cardiovascular Disease:
Time to Act, International Diabetes Federation, 2001
World Health Organisation Diabetes Unit - www.who.int/diabetes
Diabetes around the world, International Diabetes Federation, 1998.
Cost-effective Approaches to Diabetes Care and Prevention, International
Diabetes Federation, 2003